ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,758.80
0.48%
S&P ASX All Technology
3,067.10
0.12%
Brent Oil
84.135
0.22%
US Dollar vs AUD
1.51447
0.24%
Bitcoin
62,902.82
-0.23%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE
  6. Summit Therapeutics Plc (SUMM)

  7. Summit Therapeutics Plc (SUMM) News

SUMM

Summit Therapeutics (SUMM)

Summit Therapeutics Plc
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:SUMM
DateTimeSourceHeadlineSymbolCompany
18/02/202102:04PR Newswire (US)UTILITY Therapeutics Joins Antimicrobials Working GroupLSE:SUMMSummit Therapeutics Plc
24/02/202021:52Alliance NewsAlliance NewsSummit Therapeutics Delists In London As Focus Shifts To USLSE:SUMMSummit Therapeutics Plc
24/02/202018:00UK RegulatoryAIM Cancellation - Summit Therapeutics PLCLSE:SUMMSummit Therapeutics Plc
18/02/202004:30UK RegulatoryFTSE Russell Summit TherapeuticsLSE:SUMMSummit Therapeutics Plc
11/02/202021:00UK RegulatorySummit Therapeutics plc Aim Delisting ReminderLSE:SUMMSummit Therapeutics Plc
11/02/202001:15UK RegulatorySummit Therapeutics plc Director/Pdmr ShareholdingLSE:SUMMSummit Therapeutics Plc
07/02/202005:36Alliance NewsAlliance NewsSummit Therapeutics Gets USD1 Million Payment For Ridinilazole TrialLSE:SUMMSummit Therapeutics Plc
06/02/202023:00UK RegulatorySummit Therapeutics plc Summit Therapeutics To Receive $1.0 Million Milestone Payment From EurofarmaLSE:SUMMSummit Therapeutics Plc
04/02/202023:00UK RegulatorySummit Therapeutics plc Summit Therapeutics To Present At The 2020 Bio Ceo & Investor ConferenceLSE:SUMMSummit Therapeutics Plc
27/01/202018:00UK RegulatorySummit Therapeutics plc Exercise Of Restricted Stock UnitsLSE:SUMMSummit Therapeutics Plc
24/01/202023:49Alliance NewsAlliance NewsSummit Therapeutics Chief Operating & Medical Officer Roblin ResignsLSE:SUMMSummit Therapeutics Plc
24/01/202023:00UK RegulatorySummit Therapeutics plc Summit Announces Management UpdateLSE:SUMMSummit Therapeutics Plc
24/01/202003:47Alliance NewsAlliance NewsSummit Gets More Funding For C. Difficile Infection TreatmentLSE:SUMMSummit Therapeutics Plc
23/01/202023:00UK RegulatorySummit Therapeutics plc Summit Announces Barda Expands Ridinilazole Award By $8.8 Million To Include Additional Nda-Enabling ...LSE:SUMMSummit Therapeutics Plc
21/01/202001:15UK RegulatorySummit Therapeutics plc Holding(s) In CompanyLSE:SUMMSummit Therapeutics Plc
21/01/202001:15UK RegulatorySummit Therapeutics plc Holding(s) In CompanyLSE:SUMMSummit Therapeutics Plc
15/01/202023:15UK RegulatorySummit Therapeutics plc Notification Of Transactions Of Persons Discharging Managerial ResponsibilitiesLSE:SUMMSummit Therapeutics Plc
07/01/202023:00UK RegulatorySummit Therapeutics plc Summit Therapeutics Launches Online Resource For Patients With C. Difficile InfectionLSE:SUMMSummit Therapeutics Plc
31/12/201920:00UK RegulatorySummit Therapeutics plc Holding(s) In CompanyLSE:SUMMSummit Therapeutics Plc
30/12/201918:00UK RegulatorySummit Therapeutics plc Holding(s) In CompanyLSE:SUMMSummit Therapeutics Plc
24/12/201921:27Alliance NewsAlliance NewsSummit Therapeutics Shuffles Board After Raising USD50 MillionLSE:SUMMSummit Therapeutics Plc
24/12/201919:30UK RegulatorySummit Therapeutics plc Completion Of $50 Million Fundraising And Directorate ChangeLSE:SUMMSummit Therapeutics Plc
24/12/201918:01UK RegulatorySummit Therapeutics plc Award Of Share OptionsLSE:SUMMSummit Therapeutics Plc
24/12/201918:00UK RegulatorySummit Therapeutics plc Exercise Of Restricted Stock UnitsLSE:SUMMSummit Therapeutics Plc
23/12/201923:00UK RegulatorySummit Therapeutics plc Result Of General MeetingLSE:SUMMSummit Therapeutics Plc
19/12/201918:00UK RegulatorySummit Therapeutics plc Timetable UpdateLSE:SUMMSummit Therapeutics Plc
18/12/201900:20Alliance NewsAlliance NewsSummit Therapeutics Reports Decrease In Revenue In Third QuarterLSE:SUMMSummit Therapeutics Plc
17/12/201923:00UK RegulatorySummit Therapeutics plc Summit Therapeutics Reports Financial Results And Operational Progress For The Third Quarter And Nine...LSE:SUMMSummit Therapeutics Plc
17/12/201901:15UK RegulatorySummit Therapeutics plc Notice Of Q3 ResultsLSE:SUMMSummit Therapeutics Plc
07/12/201900:34Alliance NewsAlliance NewsSummit Therapeutics Plans Wholesale Changes As It Raises CashLSE:SUMMSummit Therapeutics Plc
 Showing the most relevant articles for your search:LSE:SUMM

Your Recent History

NYSE
VZ
Verizon Communications
ASX
AMP
AMP
ASX
ANZ
Australia And New Zealan...
ASX
XFL
S&P ASX 50
NASDAQ
TSLA
Tesla
ASX
ORG
Origin Energy
ASX
XAO
Australian SE All Ordina...
NYSE
NKE
Nike
FX
GBPAUD
Sterling vs AUD
FX
AUDCAD
AUD vs CAD
NASDAQ
AAPL
Apple
ASX
NCM
Newcrest Mining
ASX
WDC
Westfield
ASX
QBE
QBE Insurance
NYSE
JPM
JP Morgan Chase
ASX
MQG
Macquarie
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved